Why Antidiabetic Vanadium Complexes are Not in the Pipeline of “Big Pharma” Drug Research? A Critical Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|25|2874-2891

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.25, 2016-08, pp. : 2874-2891

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are Vanadium Compounds Drugable? Structures and Effects of Antidiabetic Vanadium Compounds: A Critical Review

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-11 ,pp. : 995-1008

Bentham Science Publishers

Access to resources Recommend Favorite

Drug price cuts in Japan affect big pharma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 356, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Big Pharma's Recent Challenges

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 1, Iss. 1, 2014-04 ,pp. : 28-36

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review

By  

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4405-4423

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Drug Delivery Systems for Anti-Diabetic Drugs: A Review

By  

Current Drug Delivery, Vol. 11, Iss. 4, 2014-06 ,pp. : 444-457

Bentham Science Publishers

Access to resources Recommend Favorite